Every 8-K that Medical Properties Trust, Inc. (MPT) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow MPT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MPT filings page.
Medical Properties Trust, Inc., through MPT Operating Partnership, L.P. and MPT Finance Corporation, entered into a material financing transaction with institutional investors, issuing $2.4 billion aggregate principal amount of new 9.25% senior secured notes due 2032 in a private placement and exchange.
The issuers intend to use the net cash proceeds to redeem in full their senior notes due 2026 and partially redeem senior notes due 2027, while the exchange component refinances approximately $1.5 billion of unsecured notes maturing between 2027 and 2031. The notes pay interest semi-annually beginning December 15, 2026 and mature on February 15, 2032, with various optional redemption features, including an equity-funded redemption of up to 40% of the notes at 109.250% of principal before August 10, 2028.
The notes are fully and unconditionally guaranteed on a joint and several basis by the company and specified subsidiaries, and are secured by first-priority liens on equity and certain real properties of first-lien guarantors, with future second-lien status tied to the revolving credit facility. The indenture includes restrictive covenants, requires total unencumbered assets of at least 150% of collective unsecured debt, and provides customary events of default and a Change of Control repurchase right at 101% of principal plus accrued interest.
Medical Properties Trust, Inc. reported second-quarter 2026 total revenues of $259.3 million, up from $240.4 million a year earlier, driven primarily by higher rent billed. The company recorded a net loss of $2.6 million (‑$0.01 per share), a substantial improvement from a $98.4 million loss (‑$0.16 per share) in the prior-year quarter. Normalized funds from operations (NFFO) were $92.2 million, or $0.15 per share, compared with $81.4 million, or $0.14 per share, reflecting better underlying operating performance despite ongoing impairments and high interest costs.
As of June 30 2026, Medical Properties Trust had total assets of $14.7 billion and a portfolio of 373 properties with approximately 38,000 licensed beds across the U.S. and eight other countries. Net investment in real estate assets was $10.9 billion. Debt, net totaled $9.7 billion, with adjusted net debt to annualized EBITDAre at 8.9x and an adjusted interest coverage ratio of 1.9x, highlighting a still-leveraged balance sheet.
Subsequent to quarter end, the company agreed to a major refinancing in which its operating partnership will issue $2.4 billion of new 9.25% senior secured notes due 2032 through a new-money private placement and private exchange. The transaction is expected to refinance multiple unsecured note maturities, reduce total principal debt by approximately $123 million to $9.5 billion, and leave only $1.3 billion of unsecured note maturities through 2028, materially extending the debt maturity profile.
Medical Properties Trust, Inc. reported results of its annual stockholder meeting held on May 28, 2026. As of the March 19, 2026 record date, 602,829,003 shares of common stock were outstanding and entitled to vote, and 468,686,557 shares were represented, establishing a quorum.
Stockholders elected nine directors to serve until the 2027 annual meeting or until their successors are elected and qualify. They also approved the ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, supported by 459,883,831 votes. In addition, stockholders approved on a non-binding, advisory basis the compensation of named executive officers and approved the Second Amended and Restated 2019 Equity Incentive Plan.
Medical Properties Trust, Inc. reported a return to profitability in the first quarter of 2026. Net income attributable to common stockholders was $32.8 million, or $0.05 per share, compared with a net loss of $118.3 million, or $(0.20) per share, a year earlier.
Total revenues rose to $252.1 million from $223.8 million, while normalized funds from operations held steady at $82.2 million, or $0.14 per share. The REIT ended the quarter with approximately $14.8 billion in total assets, a portfolio of 378 properties and about 38,000 licensed beds across nine countries. Management highlighted ramping rent payments at transitioned hospitals and reiterated confidence in collecting at least $1 billion in annualized cash rent by year-end and in addressing upcoming debt maturities.
Medical Properties Trust, Inc. reported sharply improved results for 2025, moving from a large prior-year loss to a much smaller one while stabilizing its hospital real estate portfolio. Net income for the fourth quarter was $17 million, or $0.03 per share, compared with a net loss of $413 million, or $(0.69) per share, a year earlier. For the full year, the company recorded a net loss of $277 million, or $(0.46) per share, versus a $2.4 billion loss, or $(4.02) per share, in 2024, reflecting far lower impairment charges.
Normalized funds from operations, a key REIT cash-flow metric, were $106.6 million, or $0.18 per share, for the fourth quarter, essentially flat with the prior year, and $346.3 million, or $0.58 per share, for 2025, down from $482.7 million, or $0.80 per share, in 2024. The company highlighted progress repositioning challenged tenants, including new long-term leases and asset sales, and reiterated a goal of driving pro forma annualized cash rent from its current portfolio to at least $1 billion by the end of 2026.
MPT ended 2025 with total assets of $15.0 billion and debt, net of issuance costs and discounts, of $9.7 billion, resulting in financial leverage of 59.0% and an adjusted net debt to annualized EBITDAre ratio of 8.5x. The portfolio comprised 384 properties and approximately 39,000 licensed beds across nine countries, with general acute care hospitals representing the majority of assets and revenue.